Xeris Pharmaceuticals Secures $1,125,000 New Round

  • Feed Type
  • Date
    9/26/2012
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3925 West Braker Lane Third Floor Austin, TX 78759
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. The company’s disruptive formulation and delivery technologies allow for the subcutaneous delivery of highly concentrated, non-aqueous paste and liquid formulations of all drug classes, including small molecules, peptides, proteins, antibodies, and nucleic-acid-based therapeutics.
  • Website
    http://www.xerispharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,125,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed